• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGU454520J
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Paraplegia (2448)
Event Date 12/26/2019
Event Type  Injury  
Manufacturer Narrative
Additional device: tgmr373720j, lot #: 20959146, udi: (b)(4).
 
Event Description
The following was reported to gore: on (b)(6) 2019, the patient underwent an endovascular procedure to repair an impending rupture of a descending aortic aneurysm using a conformable gore® tag® thoracic endoprosthesis (tgu454520j/19984225) and a gore® tag® conformable thoracic stent graft with active control (tgmr373720j/20959146).The procedure was completed and the patient tolerated the procedure.On the same day of the procedure, paraplegia was observed.To remedy this, spinal drainage was performed.The patient is being monitored.It was reported that the left external iliac artery rupture was thought to be due to the access vessel being thin and accordion shaped.Reportedly the physician was concerned about paraplegia before the procedure since the patient was observed to have a shaggy aorta.
 
Manufacturer Narrative
H.6.Results code 1: 213: a review of the manufacturing records for the devices verified the lots met all pre-release specifications.Conclusion code 1: 22: according to the conformable gore tag® thoracic endoprosthesis and gore® tag® conformable thoracic stent graft with active control system instructions for use, adverse events that may occur include, but is not limited to paralysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9527864
MDR Text Key184828678
Report Number2017233-2019-01279
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 12/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/04/2021
Device Catalogue NumberTGU454520J
Device Lot Number19984225
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/27/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age85 YR
-
-